caspase 9 inhibitor iii is a synthetic peptide analog incorporating a reactive moiety designed to engage catalytic cysteine sites. The sequence allows investigation of substrate-recognition motifs and protease specificity. Researchers employ it to probe apoptotic signaling pathways and enzyme kinetics. Its tailored structure supports mechanistic studies of caspase activity.
CAT No: HB00092
CAS No:403848-57-7
Synonyms/Alias:403848-57-7;Ac-Leu-Glu-His-Asp-chloromethylketone;Caspase-9 Inhibitor III(Ac-LEHD-CMK);caspase 9 inhibitor iii;FA111088;PD088788;Caspase-9 Inhibitor III(Ac-LEHD-CMK)?;Ac-DL-Leu-DL-Glu-DL-His-DL-Asp-CH2Cl;G85499;4-[(2-acetamido-4-methylpentanoyl)amino]-5-[[1-[(1-carboxy-4-chloro-3-oxobutan-2-yl)amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;
Caspase 9 Inhibitor III is a small-molecule compound designed to selectively modulate the activity of caspase-9, a key initiator protease within the intrinsic (mitochondrial) apoptotic pathway. As an essential component of programmed cell death, caspase-9 acts upstream in the apoptosome complex to activate downstream effector caspases, orchestrating cellular demolition in response to intrinsic stress signals. The precise inhibition of caspase-9 with targeted molecules such as Caspase 9 Inhibitor III enables researchers to dissect apoptosis mechanisms, evaluate mitochondrial signaling cascades, and explore the regulation of cell fate decisions in a variety of biological systems. Its specificity and functional relevance make it a valuable tool for apoptosis studies, cell biology research, and biochemical pathway analysis.
Apoptosis research: Selective inhibition of caspase-9 is fundamental for elucidating the molecular steps of the intrinsic apoptotic pathway. By employing Caspase 9 Inhibitor III, researchers can temporally control the activation of caspase-9 and downstream caspases, thereby distinguishing between mitochondrial-mediated apoptosis and alternative cell death routes. This approach is particularly useful for mapping apoptotic signaling networks, validating the role of caspase-9 in specific cellular contexts, and characterizing the consequences of caspase-9 inhibition on cell survival and stress responses.
Mitochondrial pathway dissection: In studies focused on mitochondrial integrity and cytochrome c release, caspase-9 inhibitors serve as critical reagents for pinpointing the exact step at which mitochondrial signals propagate to the execution phase of apoptosis. By blocking caspase-9 activity, investigators can decouple mitochondrial outer membrane permeabilization from downstream proteolytic events, allowing for a more nuanced analysis of apoptosome assembly, substrate cleavage, and the interplay between mitochondrial dysfunction and cell death.
Cell-based assay development: Caspase 9 Inhibitor III is widely utilized in the development and optimization of cell-based assays designed to monitor apoptosis and cell viability. Its inclusion in experimental protocols enables the validation of assay specificity, the establishment of negative controls, and the assessment of compound selectivity in high-throughput screening platforms. By modulating caspase-9 activity, assay developers can refine detection methods for apoptotic markers and improve the reliability of functional readouts in pharmacological and toxicological studies.
Signal transduction studies: Understanding the crosstalk between apoptotic and non-apoptotic signaling pathways often requires precise modulation of key proteases. Selective caspase-9 inhibition provides a means to interrogate the influence of intrinsic apoptotic signaling on broader cellular processes such as inflammation, differentiation, and metabolic regulation. By incorporating Caspase 9 Inhibitor III into signaling pathway analyses, researchers can delineate the downstream effects of mitochondrial stress and clarify the context-dependent roles of caspase-9 in various cellular phenotypes.
Protein interaction and substrate identification: The use of caspase-9 inhibitors is instrumental in identifying endogenous substrates and binding partners of caspase-9 within cellular extracts or reconstituted systems. By halting proteolytic activity at a defined step, scientists can capture transient protein complexes, analyze substrate specificity, and study the assembly of multiprotein structures such as the apoptosome. These applications contribute to a deeper understanding of caspase-9's molecular interactions and regulatory mechanisms, providing insights that are valuable for both basic research and the development of novel modulators of cell death pathways.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More